doc_id,table_id,row_index,ColumnA,ColumnB,ColumnC
WHO_TB_handbook_module6_comorbidities_2024,Table 4.3.,1,,Population,Clinical considerations
WHO_TB_handbook_module6_comorbidities_2024,Table 4.3.,2,Serum cryptococcal antigen test,Serum cryptococcal antigen test is recommended for adults and adolescents with signs and symptoms of cryptococcal meningitis or with a CD4 count <100 cells/mm 3 ; it should also be considered for persons with CD4 count <200 cells/mm 3,"If serum cryptococcal antigen is positive, proceed to lumbar puncture and CSF cryptococcal antigen testing where available"
WHO_TB_handbook_module6_comorbidities_2024,Table 4.3.,3,CSF cryptococcal antigen test,"Adults, adolescents with signs and symptoms of cryptococcal meningitis, or who have a positive serum cryptococcal antigen","If lumbar puncture is available and no contraindication to lumbar puncture For alternative diagnostic algorithms where rapid cryptococcal antigen test and/or lumbar puncture are not available, see the cryptococcal disease guidelines (155)"
WHO_TB_handbook_module6_comorbidities_2024,Table 4.3.,4,Cryptococcosis pre-emptive treatment,Adults and adolescents with serum cryptococcal antigen test positive but CSF cryptococcal antigen test negative,Maintenance treatment should continue until person is stable on ART with CD4 cell count >200 cells/mm 3
WHO_TB_handbook_module6_comorbidities_2024,Table 4.3.,5,Cryptococcal disease treatment,Adults and adolescents with serum cryptococcal antigen test positive and CSF cryptococcal antigen test positive,"The preferred induction regimen for adults, adolescents and children is a single high dose (10 mg/kg) of liposomal amphotericin B with 14 days of flucytosine (100 mg/kg per day divided into four doses per day) and fluconazole (1200 mg/daily for adults; 12 mg/ kg per day for children and adolescents up to a maximum of 800 mg daily). Alternative regimens for settings where first-line induction regimen is unavailable are provided in the cryptococcal disease guidelines (155)"